The Various Effects of Gaseous Albuterol on Serum Lactate

Completed · Not applicable

Conditions studied: Asthma

In brief

Empirical data from physician observation indicates an increase in serum lactate in acute asthmatic patients being treated with inhaled albuterol therapy. It is not clear if this increased serum lactate is in response to a physiological response to the asthmatic process or from the albuterol treatment. This study is designed to determine if administration of inhaled albuterol increases serum lactate in healthy subjects.

Key facts

Study ID

NCT02073747

Run by

University Medical Center of Southern Nevada

People needed

28

Starts

2015-04-01

Expected to finish

2015-08-01

Last updated by the study team

2017-08-14

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years or older

You may not qualify if…

• Pregnant
• Prisoner
• beta agonist allergy
• hypokalemia
• taking furosemide, insulin, thiazide diuretics, metformin or acetazolamide
• coronary artery disease
• hyperthyroidism
• abnormal heart rhythm
• baseline serum lactate level >2.2 mmol/L
• baseline heart rate > 120

Where it is running

• University Medical Center of Southern Nevada — Las Vegas, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.